3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
5
Terminated
2
Recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Adrenocortical Carcinoma
1
Interventions
lutetium Lu 177 dotatate
6
Everolimus
6
lanreotide
5
anlotinib
5
Temozolomide
5
Injections
4
Dexmedetomidine
4
Cisplatin
4
surufatinib
3
Thyrotropin Alfa
3
Sodium Chloride
3
Saline Solution
3
Fluorodeoxyglucose F18
3
Blood Specimen Collection
3
177Lu-octreotide, DOTA(0)-Tyr(3)-
3
(177)Lu-DOTA-EB-TATE
3
sintilimab
2
penpulimab
2
cabozantinib
2
Surgical Procedures, Operative
2
Sorafenib
2
Rosiglitazone
2
Radiotherapy
2
Radiofrequency Ablation
2
Positron Emission Tomography Computed Tomography
2
Paclitaxel
2
Nivolumab
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Metformin
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mitotane
×
Endocrine
×
Clear all
NCT00777244
2017-05-08
ADIUVO
University of Turin, Italy
Phase 3
Unknown
200 enrolled